Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Price:
1.57 USD
6.08%
Market Closed
Updated:
May 8, 2024
Marinus Pharmaceuticals Inc
Net Income (Common)
|
Marinus Pharmaceuticals Inc
Net Income (Common) Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
|
Net Income (Common)
-$141.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Net Income (Common)
$38.5B
|
CAGR 3-Years
37%
|
CAGR 5-Years
21%
|
CAGR 10-Years
10%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Net Income (Common)
-$6.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Net Income (Common)
-$309m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Net Income (Common)
$2.3B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-7%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Net Income (Common)
$6.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
See Also
What is Marinus Pharmaceuticals Inc's Net Income (Common)?
Net Income (Common)
-141.4m
USD
-141.4m
USD
Based on the financial report for Dec 31, 2023, Marinus Pharmaceuticals Inc's Net Income (Common) amounts to -141.4m USD.
What is Marinus Pharmaceuticals Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-31%
-31%
Over the last year, the Net Income (Common) growth was -613%. The average annual Net Income (Common) growth rates for Marinus Pharmaceuticals Inc have been -23% over the past three years , -31% over the past five years .
You don't have any saved screeners yet
